[Peculiarities in the course of malignant diseases of the hemopoietic & lymphoreticular systems under cytostatic treatment].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D054697:Cytostatic Agents; D006413:Hematopoietic System; D006801:Humans; D009369:Neoplasms
D000970:Antineoplastic Agents; D054697:Cytostatic Agents
CYTOTOXIC DRUGS/therapeutic use; HEMOPOIETIC SYSTEM/neoplasms
Besonderheiten im Verlauf der malignen Erkrankungen des hämatopoetischen und lymphoreticulären Systems unter cytostatischer Behandlung.